Overview

A Study of Tadalafil in Men With Benign Prostatic Hyperplasia

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether an experimental drug known as tadalafil given once daily can reduce the symptoms associated with Benign Prostatic Hyperplasia (straining, urinary frequency, feeling like your bladder is still full etc.)
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Tadalafil
Tamsulosin